MedCity News

How the Health Sector Can Change Vaccine Messaging Amid Rising Anti-Vaccine Sentiment

Why One Healthcare Founder Never Took Venture Capital

Randy Bolyga, founder CEO of RXNT, built his medical software company without venture capital, relying instead on SBA loans and a conservative, cash-positive growth strategy. He believes many venture capital-backed healthcare startups fail because they chase rapid growth without sustainable business models or a deep understanding of the market.

By Katie Adams

MedCity Influencers

Medical Device Right to Repair is the Wrong Approach

How can physicians and patients be confident enough that vendors entirely ignorant of the FDA process for repair and reporting can properly recalibrate life-saving machines? Is this really the right place to argue that “anyone can do it?”

By Peter J. Pitts

Sponsored Post

How to Optimize Your Phlebotomy Setup for Efficient Patient Care

The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.

By CAPSA

Latest News

MedCity Influencers

When Patients Win, Everyone Wins

When was the last time you asked a patient to contribute to trial design? Have you ever asked a patient to contribute to a protocol? Patient-centricity benefits the entire healthcare ecosystem.

By Suzanne Harris

Startups, Health Tech Consumer / Employer,

New Pregnancy App Launches to Support Mothers Through Birth and Beyond

Trellis Health emerged from stealth and announced $1.8 million in pre-seed funding. The platform helps women easily access and understand their medical records so they can make better health decisions during pregnancy and throughout their lives.

By Katie Adams

Sponsored Post

Changes in Nurse Staffing Answer Clinician Demands

The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.

By Tomasz Rezik

Health Tech

Peterson Center on Healthcare: 3 Policy Recommendations for Remote Health Technologies

In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection for remote monitoring technologies.

By Marissa Plescia

BioPharma, Pharma

Eli Lilly’s Metabolic Medicine Takes the Lead in the Race to Develop an Oral GLP-1 Drug

The first Phase 3 results for Eli Lilly’s daily pill orforglipron show statistically significant reductions in blood sugar and body weight in patients with type 2 diabetes. The pharmaceutical giant plans global regulatory submissions starting at the end of this year.

By Frank Vinluan

MedCity Influencers

Health Plans Can Reduce Costs with a Focus on Rising Risk

Healthcare organizations need to jump in with both feet when it comes to AI, as mitigating risk is quickly becoming an existential business issue. Machine learning has quickly gone from being a nice-to-have to a must-have.

By David Hamilton

MedCity Influencers

The Rise of Plant-Based Self-Medication and What Healthcare Must Do Next

The self-medicating plant movement sits at the intersection of empowerment and misinformation. On one hand, it signals a growing desire for agency in personal health. On the other, it raises alarms about safety, oversight, and the risk of delayed care.

By David DeSouza

BioPharma, Startups

Startup Glycomine Lands $115M for Clinical Trial in Ultra-Rare Disease With No Approved Drugs

Glycomine’s lead program is an experimental treatment for PMM2-CDG, an ultra-rare enzyme deficiency often misdiagnosed as cerebral palsy. With encouraging results from an open-label Phase 2 study, the biotech startup is now preparing for a placebo-controlled test that could potentially support a regulatory submission.

By Frank Vinluan

Sponsored Post

Consultants: Help Define What’s Next In Healthcare Benefits

Help shape the future of healthcare benefits by sharing your insights.

By MedCity News

Policy

Trump’s Executive Order on Prescription Drug Costs Delivers a Win for Pharma Companies

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain drugs can be selected for negotiation.

By Marissa Plescia

MedCity Influencers

Healthcare’s Robotic Renaissance: Meeting Future Demands

From the operating room to the front desk, robotics are now being integrated into a variety of applications with the purpose of freeing up time and services for healthcare workers to do what they do best, patient care.

By Winston Leung

MedCity Influencers

How the Healthcare Industry Can Soften Blow from Medicaid Cuts

By adopting a fresh approach that places the right people in the right programs, including AI-enabled enrollment, health plans, the healthcare industry will be in a better position to weather impending federal cuts – and maybe even end up better for it.

By Pedram Afshar

Sponsored Post

How Can Fintech Make it Easier for Early Stage Life Science Companies to Grow?

A webinar on May 8th will explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies.

By Stephanie Baum

Startups, Health Tech, Providers Physicians,

Adventist HealthCare Teams Up with Culina Health to Expand Access to Nutrition Care

Digital nutrition company Culina Health is joining forces with Adventist HealthCare’s clinically integrated network of more than 2,400 providers. Under the partnership, Adventist physicians will have direct access to Culina Health’s dietitians, who provide patients with virtual, personalized nutrition counseling.

By Katie Adams

Payers, Providers

What SCAN and Sutter Health Hope to Achieve with Their MA Partnership

SCAN Group is partnering with Sutter Health to develop new Medicare Advantage products and eventually launch a joint venture Medicare Advantage plan.

By Marissa Plescia

Devices & Diagnostics, BioPharma

Software-as-Treatment Startup Click Therapeutics Gets FDA Authorization for Migraine Mobile App

Click Therapeutics’ migraine mobile app may now be used alongside standard drug therapies as a way to prevent episodic migraine in adults. In clinical trials, daily use of the app led to a statistically significant reduction in monthly migraine days.

By Frank Vinluan

MedCity Influencers

Diabetes Eradication? The New Chronic Condition Care Playbook and How GLP-1s Are Changing the Game

GLP-1 medications are transforming how we think about chronic disease management and, more importantly, prevention. Ongoing research has found them to be effective in the prevention or treatment of diabetes, heart attacks and strokes, kidney disease, liver disease, sleep apnea, and more.

By Tim Church